StockWatch
·
Pharmaceuticals
Quarterly Result27 May 2026, 06:42 pm

Supriya Lifescience: FY26 Audited Results; Dividend of ₹1/Share

AI Summary

Supriya Lifescience Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹1.00 per equity share (50% on face value of ₹2), subject to shareholder approval at the upcoming Annual General Meeting. The board meeting commenced at 3:45 p.m. and concluded at 6:00 p.m.

Key Highlights

  • Audited financial results for the quarter and year ended March 31, 2026, approved.
  • Final dividend of ₹1.00 per share recommended, subject to shareholder approval.
  • Auditor's report states the financial results present a true and fair view.
  • Meeting commenced at 3:45 p.m. and concluded at 6:00 p.m.